as on December 11, 2025 at 2:29 am IST
Day's Low
Day's High
9.43%
Downside
1.08%
Upside
52 Week's Low
52 Week's High
90.67%
Downside
1.08%
Upside
Check Olema Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
-1.9622
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-160.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-59.23%
Compare market cap, revenue, PE, and other key metrics of Olema Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.1B | -29.11% | NA | 0.00% | |
| BUY | $40.5B | 375.93% | -16.34 | -264.83% | |
| BUY | $54.9B | 211.96% | 1384.03 | 1.36% | |
| BUY | $112.0B | 98.35% | 30.8 | 31.35% | |
| BUY | $73.4B | 51.37% | 16.61 | 32.13% |
The Olema Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Olema Pharmaceuticals Inc investment value today
Current value as on today
₹3,70,269
Returns
₹2,70,269
(+270.27%)
Returns from Olema Pharmaceuticals Inc Stock
₹2,64,328 (+264.33%)
Dollar Returns*
₹5,941 (+5.94%)
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Olema Pharmaceuticals Inc. Average target price of $36.5
Get share price movements and forecasts by analysts on Olema Pharmaceuticals Inc.
What analysts predicted
16.05%UPSIDE
Target Price
$36.5
Current Price
$30.64
Analyzed by
16 Analysts
Target
$36.50
Olema Pharmaceuticals Inc target price $36.5, a slight upside of 16.05% compared to current price of $30.64. According to 16 analysts rating.
Investment in Olema Pharmaceuticals Inc Shares on INDmoney has grown by 3328.57% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:3328.57% versus previous 30 day period
Search interest for Olema Pharmaceuticals Inc Stock has increased by 2093% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2093% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 18 November
Tue, 08:26 PM
-Olema Pharmaceuticals stock surged over 200% following positive Phase 3 results from Roche's breast cancer study.
Wed, 03:22 AM
-Olema Pharmaceuticals terminates ATM Prospectus, maintaining Sales Agreement but facing financial challenges.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, OLMA stock has moved up by 224.5%
Best in 1 Year
![]()
In the last 1 year, OLMA has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, OLMA has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Olema Pharmaceuticals Inc |
| Headquarters | 780 Brannan Street, San Francisco, CA, United States, 94103 |
| Industry | Health Technology |
| CEO | Dr. Sean P. Bohen M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Sean P. Bohen M.D., Ph.D. | President, CEO & Director |
Ms. Julie Dexter | Senior VP & Head of People |
Dr. David C. Myles Ph.D. | Chief Discovery & Non-Clinical Development Officer |
Mr. Richard Hernandez | Senior Vice President of Clinical Development Operations |
Mr. Shane William Charles Kovacs M.B.A. | Chief Operating & Financial Officer |
Dr. Naseem Zojwalla M.D. | Chief Medical Officer |
Ms. Shawnte M. Mitchell J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Courtney O'Konek | Vice President of Corporate Communications |
Dr. Mark Shilkrut M.D., Ph.D. | Senior Vice President of Clinical Development |
Dr. Kamesh Kuchimanchi Ph.D. | Senior Vice President of Regulatory Affairs & Quality Assurance |
Olema Pharmaceuticals Inc share price today is $30.64 as on at the close of the market. Olema Pharmaceuticals Inc share today touched a day high of $30.97 and a low of $27.75.
Olema Pharmaceuticals Inc share touched a 52 week high of $30.97 on and a 52 week low of $2.86 on . Olema Pharmaceuticals Inc stock price today i.e. is closed at $30.64,which is 1.07% down from its 52 week high and 971.33% up from its 52 week low.
Olema Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Olema Pharmaceuticals Inc (OLMA) shares with as little as ₹89.928 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.28 in Olema Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Olema Pharmaceuticals Inc share’s latest price of $30.64 as on December 11, 2025 at 2:29 am IST, you will get 0.3264 shares of Olema Pharmaceuticals Inc. Learn more about
fractional shares .
Olema Pharmaceuticals Inc stock has given -29.11% share price returns and 22.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?